Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy

R. S. Bahn, C. A. Gorman

Research output: Contribution to journalReview articlepeer-review

74 Scopus citations

Abstract

Treatment recommended for thyroid-associated ophthalmopathy varies with the particular expression of the disease in a given patient. Medical therapy may be beneficial in the early phase before extensive fibrosis of retro-ocular muscles and connective tissue is established. Although corticosteroids reliably suppress acute inflammatory changes, evidence supporting efficacy of plasmapheresis, immunosuppressive drugs, iodine-131 ablation, and radiotherapy is inconclusive. Surgery on eyelids, extraocular muscles, and orbit effectively rehabilitates most patients with even the most severe ophthalmopathy while having no effect on the underlying autoimmune process. Future research should include continued attempts to identify the putative target antigens in the orbit and to define the controls of glycosaminoglycan synthesis. Until prevention by immunologic or other medical means is attainable, surgery on orbit, muscles, and eyelids appears the most effective mode of treatment for correction of the functional and cosmetic consequences of the ophthalmopathy associated with autoimmune thyroid disease.

Original languageEnglish (US)
Pages (from-to)391-407
Number of pages17
JournalEndocrinology and Metabolism Clinics of North America
Volume16
Issue number2
DOIs
StatePublished - 1987

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Choice of therapy and criteria for assessing treatment outcome in thyroid-associated ophthalmopathy'. Together they form a unique fingerprint.

Cite this